BioPharma Pharma Research
The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...
October 16, 2023 | News
HanAll Biopharma and Daewoong Pharmaceutical marked a pivotal step forward in the development of HL192 (ATH-399A) for the potential treatment of Parkinso...
October 13, 2023 | News
Unique from current CT technology, GE HealthCare’s proprietary photon counting CT design is engineered to leverage Deep Silicon detectors with the ...
October 10, 2023 | News
MENA and South Asia are recognized as pivotal regions for Kexing Biopharm's overseas business expansion. The event brought together industry experts and he...
October 10, 2023 | News
"The positive findings from biomarker and patient subgroup analyses from the Phase 3 NefIgArd study highlights that Nefecon® treatment results in ...
October 05, 2023 | News
The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class tr...
October 03, 2023 | News
The launch of the new base in Shanghai will enhance OBiO's production and service capabilities in both China and the United States...
September 28, 2023 | News
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), h...
September 21, 2023 | News
"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...
September 20, 2023 | News
The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...
September 18, 2023 | News
"We are excited to work with NCCS to uncover the unique molecular genomic composition of cancers prevalent in Asia by providing our DNBSEQ-G400 s...
September 18, 2023 | News
Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...
September 18, 2023 | News
In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...
September 14, 2023 | News
Takara Bio Europe (TBE) announced the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...
September 13, 2023 | News
Most Read
Bio Jobs
News